The INVEST Precision Medicine conference cast a spotlight on the role of children's hospitals, biopharma companies, diagnostic companies and startups in biopharma innovation. The video recordings of the conference sessions are now available to view.
A panel discussion on non dilutive funding sources for biopharma and medtech startups from government research and industry grants to industry partnerships and venture debt.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
On the final day of INVEST Precision Medicine, a panel with Caris Health, CVS Health, and Intermountain Healthcare will share assessments of precision medicine's progress and the outlook for this sector. Also, a panel will highlight non dilutive funding opportunities for startups. Register now!
The conference will include conversations with healthcare industry experts from The Steve & Cindy Rasmussen Institute for Genomic Medicine, Nationwide Children's Hospital, Vineti, Ori Biotech, CVS Caremark, Caris Life Sciences, HHS, University City Science Center, and more.
The panel, What It Takes To Build A Successful, Regional BioInnovation Hub (sponsored by Independence Blue Cross) focuses on Philadelphia — one of many cities seeking to support the continued growth of cell and gene therapy and connected health industries.
A video from the conference spotlights startup pitches with Q&A from judges in the Health IT track of the Pitch Perfect contest.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
University City Science Center, a Philadelphia-based nonprofit, launched a new accelerator for technology-enabled startups. The first seven companies in its cohort will bring their technical expertise to healthcare.
The MedCity CONVERGE conference at the University City Science Center June 19 in Philadelphia will be the scene of a dynamic series of conversations around cancer treatment, precision medicine, value-based care and investment trends. It will spotlight industry experts, presentations from innovative startups and collaborations.
The University City Science Center's DHA program created a blind initial application process that focuses on the founders’ ability to communicate their idea with the goal of removing biases associated with how screeners perceive the founding team.
Of the seven companies selected to take part spanning caregiver support as an employee benefit to global guidance on regulatory and reimbursement issues for biopharma and medtech companies, most are led by women.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
Quantitative Radiology Solutions, a Philadelphia, Pennsylvania-based startup focused on radiation treatment planning, won the health IT under $2 million track of MedCity's Pitch Perfect contest.
Militia Hill Ventures is on a mission to build a self-sustaining life sciences ecosystem in Philadelphia — one that isn't as prone to the historical highs and lows of the local industry.
InvisALERT developed a workflow tool using a wearable to improve the way psychiatric hospital staff monitors patients.
The idea is to give researchers developing life science and other technologies that take longer to get to market another funding source.
JMC Investment took a majority stake in French medical imaging business in Keosys, a participant in the inaugural class.